News & Updates
Filter by Specialty:
Novel RSV vaccine safe to use in solid organ transplant recipients
Two doses of mRNA-1345 respiratory syncytial virus (RSV) vaccine 50 µg administered 56 days apart do not yield any safety concerns and are well-tolerated among solid organ transplant recipients (SOTRs), according to a study presented at IDWeek 2025.
Novel RSV vaccine safe to use in solid organ transplant recipients
17 Nov 2025
Novel mRNA-based vaccine prevents flu infection in adults
The novel mRNA-based influenza vaccine mRNA-1010 has demonstrated superior efficacy over its standard-dose (SD) comparator in preventing RT-PCR–confirmed protocol-defined influenza disease in adults aged 50 years and above, reports a study presented at IDWeek 2025.
Novel mRNA-based vaccine prevents flu infection in adults
17 Nov 2025
DS-5670d vaccine against COVID-19 not inferior to BNT162b2
A single dose of the omicron XBB.1.5-targeting COVID-19 mRNA vaccine DS-5670d demonstrates immunogenic non-inferiority to BNT162b2 in individuals with or without a history of prior SARS-CoV-2 infection or COVID-19 vaccination, reports a study.
DS-5670d vaccine against COVID-19 not inferior to BNT162b2
14 Nov 2025
Post-exertional malaise prevalent in adults with long COVID
A systematic review and meta-analysis reports a high prevalence of post-exertional malaise (PEM) in individuals with post-COVID-19 condition (PCC).
